Procter & Gamble Health Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Dec 2025 is 20.69% vs -0.06% in Dec 2024

Standalone Net Profit

YoY Growth in quarter ended Dec 2025 is -14.64% vs 26.13% in Dec 2024

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2025 is -10.51% vs 21.43% in Dec 2024

Interest

YoY Growth in quarter ended Dec 2025 is -33.33% vs -21.05% in Dec 2024

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024

Compare Quarterly Results Of P & G Health Ltd With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

373.86

553.63

-179.77

-32.47%

Other Operating Income

0.00

Total Operating income

373.86

553.63

-179.77

-32.47%

Raw Material Cost

84.47

255.50

-171.03

-66.94%

Purchase of Finished goods

13.32

17.75

-4.43

-24.96%

(Increase) / Decrease In Stocks

12.03

-0.90

12.93

1,436.67%

Employee Cost

61.81

95.14

-33.33

-35.03%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

91.77

104.94

-13.17

-12.55%

Total Expenditure (Excl Depreciation)

263.40

472.43

-209.03

-44.25%

Operating Profit (PBDIT) excl Other Income

110.46

81.20

29.26

36.03%

Other Income

4.36

103.24

-98.88

-95.78%

Operating Profit (PBDIT)

114.82

184.44

-69.62

-37.75%

Interest

0.10

27.25

-27.15

-99.63%

Exceptional Items

0.00

Gross Profit (PBDT)

114.72

157.19

-42.47

-27.02%

Depreciation

5.90

22.40

-16.50

-73.66%

Profit Before Tax

108.82

134.80

-25.98

-19.27%

Tax

31.23

12.91

18.32

141.91%

Provisions and contingencies

0.00

Profit After Tax

77.59

121.90

-44.31

-36.35%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

77.59

121.90

-44.31

-36.35%

Equity Capital

16.60

92.17

-75.57

-81.99%

Face Value

10.00

0.00

Reserves

0.00

Earnings per share (EPS)

46.74

13.23

33.51

253.29%

Diluted Earnings per share

46.74

13.22

33.52

253.56%

Operating Profit Margin (Excl OI)

29.55%

14.67%

0.00

14.88%

Gross Profit Margin

30.69%

28.39%

0.00

2.30%

PAT Margin

20.75%

22.02%

0.00

-1.27%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 373.86 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is 15.06% vs -4.08% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 20.69% vs -0.06% in Dec 2024

Quarterly - Standalone Net Profit

Standalone Net Profit 77.59 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -12.37% vs 33.79% in Sep 2025

YoY Growth in quarter ended Dec 2025 is -14.64% vs 26.13% in Dec 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 110.46 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -8.16% vs 33.13% in Sep 2025

YoY Growth in quarter ended Dec 2025 is -10.51% vs 21.43% in Dec 2024

Quarterly - Interest

Interest 0.10 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -16.67% vs 0.00% in Sep 2025

YoY Growth in quarter ended Dec 2025 is -33.33% vs -21.05% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 29.55%

in Dec 2025

Figures in %

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024